Premium
Cross‐resistance relationships between neonicotinoids and pymetrozine in Bemisia tabaci (Hemiptera: Aleyrodidae)
Author(s) -
Gorman Kevin,
Slater Russell,
Blande James D,
Clarke Alison,
Wren Jodie,
McCaffery Alan,
Denholm Ian
Publication year - 2010
Publication title -
pest management science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.296
H-Index - 125
eISSN - 1526-4998
pISSN - 1526-498X
DOI - 10.1002/ps.1989
Subject(s) - imidacloprid , acetamiprid , whitefly , neonicotinoid , biology , thiamethoxam , cross resistance , homoptera , genetics , toxicology , pest analysis , botany , pesticide , agronomy
BACKGROUND: Although cross‐resistance between compounds in the same insecticide group is a frequently observed phenomenon, cross‐resistance between groups that differ in structural and functional characteristics can be extremely unpredictable. In the case of controlling the whitefly, Bemisia tabaci Gennadius, neonicotinoids and the pyridine azomethine antifeedant pymetrozine represent independent lines of discovery that should be suited for alternation to avoid prolonged selection for the same resistance mechanism. Reports of an association between responses to neonicotinoids and pymetrozine were investigated by resistance profiling of seven B. tabaci strains and complementary reciprocal selection experiments. RESULTS: All strains demonstrated a consistent correlation between responses to three neonicotinoid compounds: thiamethoxam, imidacloprid and acetamiprid. Responses to neonicotinoids for six field strains clearly correlated with responses to pymetrozine. Reciprocal selection experiments confirmed an unexpected case of intergroup cross‐resistance. A seventh strain exhibited a so far unique phenotype of strong resistance to pymetrozine but full susceptibility to neonicotinoids. Selection experiments confirmed that in this strain the mechanism of pymetrozine resistance is specific and has no implications for neonicotinoids. CONCLUSION: Cross‐resistance between neonicotinoids and pymetrozine in B. tabaci probably reflects the overexpression of a cytochrome‐P450‐dependent monooxygenase capable of metabolising both types of compound in spite of their apparent structural dissimilarity. Given the predominance of this mechanism in B. tabaci, both can contribute to resistance management but should be placed within the same treatment ‘window’. Copyright © 2010 Society of Chemical Industry